JAZZ logo

Jazz Pharmaceuticals (JAZZ) Cash from investing

annual CFI:

-$508.19M-$345.13M(-211.66%)
December 31, 2024

Summary

  • As of today (May 21, 2025), JAZZ annual cash flow from investing activities is -$508.19 million, with the most recent change of -$345.13 million (-211.66%) on December 31, 2024.
  • During the last 3 years, JAZZ annual CFI has risen by +$4.70 billion (+90.25%).
  • JAZZ annual CFI is now -9622.11% below its all-time high of $5.34 million, reached on December 31, 2007.

Performance

JAZZ Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZcash flow metrics

quarterly CFI:

-$168.93M+$24.36M(+12.60%)
March 1, 2025

Summary

  • As of today (May 21, 2025), JAZZ quarterly cash flow from investing activities is -$168.93 million, with the most recent change of +$24.36 million (+12.60%) on March 1, 2025.
  • Over the past year, JAZZ quarterly CFI has increased by +$102.97 million (+37.87%).
  • JAZZ quarterly CFI is now -122.92% below its all-time high of $737.13 million, reached on March 31, 2021.

Performance

JAZZ quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZcash flow metrics

TTM CFI:

-$405.22M+$102.97M(+20.26%)
March 1, 2025

Summary

  • As of today (May 21, 2025), JAZZ TTM cash flow from investing activities is -$405.22 million, with the most recent change of +$102.97 million (+20.26%) on March 1, 2025.
  • Over the past year, JAZZ TTM CFI has increased by +$24.92 million (+5.79%).
  • JAZZ TTM CFI is now -647.40% below its all-time high of $74.03 million, reached on September 30, 2013.

Performance

JAZZ TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

JAZZ Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-211.7%+37.9%+5.8%
3 y3 years+90.3%-353.0%+93.2%
5 y5 years-227.2%-181.2%-6.2%

JAZZ Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-211.7%+90.3%-178.9%+47.9%-207.1%+93.2%
5 y5-year-227.2%+90.3%-122.9%+97.1%-207.1%+93.2%
alltimeall time-9622.1%+90.3%-122.9%+97.1%-647.4%+93.2%

JAZZ Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$168.93M(-12.6%)
-$405.22M(-20.3%)
Dec 2024
-$508.19M(+211.7%)
-$193.29M(-190.3%)
-$508.19M(+138.5%)
Sep 2024
-
$214.09M(-183.3%)
-$213.11M(-64.6%)
Jun 2024
-
-$257.09M(-5.4%)
-$601.50M(+39.8%)
Mar 2024
-
-$271.90M(-367.1%)
-$430.14M(+163.8%)
Dec 2023
-$163.06M(-63.5%)
$101.80M(-158.4%)
-$163.06M(-72.3%)
Sep 2023
-
-$174.30M(+103.3%)
-$589.24M(+43.6%)
Jun 2023
-
-$85.74M(+1678.1%)
-$410.34M(-0.8%)
Mar 2023
-
-$4.82M(-98.5%)
-$413.76M(-7.3%)
Dec 2022
-$446.23M(-91.4%)
-$324.38M(-7148.6%)
-$446.23M(+238.2%)
Sep 2022
-
$4.60M(-105.2%)
-$131.94M(-19.2%)
Jun 2022
-
-$89.16M(+139.1%)
-$163.36M(-97.3%)
Mar 2022
-
-$37.29M(+269.5%)
-$5.99B(+14.9%)
Dec 2021
-$5.21B(+417.2%)
-$10.09M(-62.4%)
-$5.21B(+1.6%)
Sep 2021
-
-$26.81M(-99.5%)
-$5.13B(-4.7%)
Jun 2021
-
-$5.91B(-902.1%)
-$5.38B(+2457.1%)
Mar 2021
-
$737.13M(+906.7%)
-$210.46M(-79.1%)
Dec 2020
-$1.01B(+548.9%)
$73.22M(-126.2%)
-$1.01B(-18.7%)
Sep 2020
-
-$279.64M(-62.3%)
-$1.24B(+10.7%)
Jun 2020
-
-$741.16M(+1133.6%)
-$1.12B(+193.6%)
Mar 2020
-
-$60.08M(-62.2%)
-$381.43M(+145.6%)
Dec 2019
-$155.30M(-60.6%)
-$159.05M(-0.4%)
-$155.30M(-455.0%)
Sep 2019
-
-$159.66M(+5952.4%)
$43.74M(+275.2%)
Jun 2019
-
-$2.64M(-101.6%)
$11.66M(-106.6%)
Mar 2019
-
$166.05M(+315.2%)
-$176.29M(-55.3%)
Dec 2018
-$394.49M(+46.7%)
$39.99M(-120.9%)
-$394.49M(-15.4%)
Sep 2018
-
-$191.75M(+0.6%)
-$466.36M(-2.4%)
Jun 2018
-
-$190.58M(+265.5%)
-$477.96M(+50.5%)
Mar 2018
-
-$52.15M(+63.6%)
-$317.52M(+18.1%)
Dec 2017
-$268.95M(-84.6%)
-$31.88M(-84.3%)
-$268.95M(+12.6%)
Sep 2017
-
-$203.35M(+574.4%)
-$238.93M(-84.7%)
Jun 2017
-
-$30.15M(+743.6%)
-$1.57B(-10.1%)
Mar 2017
-
-$3.57M(+92.3%)
-$1.74B(-0.5%)
Dec 2016
-$1.75B(>+9900.0%)
-$1.86M(-99.9%)
-$1.75B(-0.1%)
Sep 2016
-
-$1.53B(+642.3%)
-$1.75B(+672.8%)
Jun 2016
-
-$206.27M(+1619.6%)
-$226.79M(+596.9%)
Mar 2016
-
-$11.99M(+256.3%)
-$32.54M(+1343.1%)
DateAnnualQuarterlyTTM
Dec 2015
-$2.25M(-99.8%)
-$3.37M(-34.7%)
-$2.25M(-82.7%)
Sep 2015
-
-$5.16M(-57.1%)
-$13.06M(-85.7%)
Jun 2015
-
-$12.02M(-165.7%)
-$91.04M(-1.2%)
Mar 2015
-
$18.29M(-229.1%)
-$92.15M(-91.4%)
Dec 2014
-$1.07B(+6464.5%)
-$14.17M(-83.0%)
-$1.07B(+1.0%)
Sep 2014
-
-$83.14M(+533.1%)
-$1.06B(+8.2%)
Jun 2014
-
-$13.13M(-98.6%)
-$976.59M(+1.0%)
Mar 2014
-
-$957.20M(>+9900.0%)
-$967.02M(+5845.8%)
Dec 2013
-$16.26M(-95.9%)
-$3.10M(-1.6%)
-$16.26M(-122.0%)
Sep 2013
-
-$3.15M(-11.6%)
$74.03M(+0.8%)
Jun 2013
-
-$3.57M(-44.6%)
$73.43M(-115.2%)
Mar 2013
-
-$6.44M(-107.4%)
-$484.25M(+22.5%)
Dec 2012
-$395.29M(+386.6%)
$87.19M(-2425.7%)
-$395.29M(-27.9%)
Sep 2012
-
-$3.75M(-99.3%)
-$548.08M(-1.8%)
Jun 2012
-
-$561.24M(-780.2%)
-$557.96M(<-9900.0%)
Mar 2012
-
$82.51M(-225.8%)
$2.47M(-103.0%)
Dec 2011
-$81.23M(+3690.6%)
-$65.60M(+381.6%)
-$81.23M(+385.1%)
Sep 2011
-
-$13.62M(+1561.2%)
-$16.75M(+326.1%)
Jun 2011
-
-$820.00K(-31.2%)
-$3.93M(-8.3%)
Mar 2011
-
-$1.19M(+7.0%)
-$4.29M(+100.0%)
Dec 2010
-$2.14M(-65.0%)
-$1.11M(+38.1%)
-$2.14M(-64.7%)
Sep 2010
-
-$806.00K(-31.4%)
-$6.07M(-15.3%)
Jun 2010
-
-$1.18M(-223.6%)
-$7.17M(+13.7%)
Mar 2010
-
$951.00K(-118.9%)
-$6.31M(+3.0%)
Dec 2009
-$6.12M(-48.7%)
-$5.04M(+164.8%)
-$6.12M(-24.2%)
Sep 2009
-
-$1.91M(+510.6%)
-$8.07M(<-9900.0%)
Jun 2009
-
-$312.00K(-127.4%)
$51.00K(-100.6%)
Mar 2009
-
$1.14M(-116.3%)
-$7.88M(-34.0%)
Dec 2008
-$11.94M(-323.8%)
-$6.99M(-212.4%)
-$11.94M(-367.9%)
Sep 2008
-
$6.22M(-175.5%)
$4.46M(-133.7%)
Jun 2008
-
-$8.24M(+181.6%)
-$13.23M(+112.3%)
Mar 2008
-
-$2.93M(-131.1%)
-$6.23M(-216.8%)
Dec 2007
$5.34M(-454.1%)
$9.40M(-182.0%)
$5.34M(-231.2%)
Sep 2007
-
-$11.47M(+823.5%)
-$4.07M(-155.0%)
Jun 2007
-
-$1.24M(-114.4%)
$7.40M(-14.4%)
Mar 2007
-
$8.64M
$8.64M
Dec 2006
-$1.51M(-99.0%)
-
-
Dec 2005
-$153.75M
-
-

FAQ

  • What is Jazz Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals annual CFI year-on-year change?
  • What is Jazz Pharmaceuticals quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals quarterly CFI year-on-year change?
  • What is Jazz Pharmaceuticals TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals TTM CFI year-on-year change?

What is Jazz Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of JAZZ is -$508.19M

What is the all time high annual CFI for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high annual cash flow from investing activities is $5.34M

What is Jazz Pharmaceuticals annual CFI year-on-year change?

Over the past year, JAZZ annual cash flow from investing activities has changed by -$345.13M (-211.66%)

What is Jazz Pharmaceuticals quarterly cash flow from investing activities?

The current quarterly CFI of JAZZ is -$168.93M

What is the all time high quarterly CFI for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high quarterly cash flow from investing activities is $737.13M

What is Jazz Pharmaceuticals quarterly CFI year-on-year change?

Over the past year, JAZZ quarterly cash flow from investing activities has changed by +$102.97M (+37.87%)

What is Jazz Pharmaceuticals TTM cash flow from investing activities?

The current TTM CFI of JAZZ is -$405.22M

What is the all time high TTM CFI for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high TTM cash flow from investing activities is $74.03M

What is Jazz Pharmaceuticals TTM CFI year-on-year change?

Over the past year, JAZZ TTM cash flow from investing activities has changed by +$24.92M (+5.79%)
On this page